Navigation Links
Positive Data from Arena Pharmaceuticals' Pivotal BLOOM Trial Demonstrate that Lorcaserin Significantly Improved Markers of Cardiovascular Risk and Glycemic Parameters and was not Associated with Depression or Suicidal Ideation
Date:10/25/2009

.1%). Discontinuation rates for adverse events were similar in the lorcaserin and placebo groups for Year 1 and Year 2 (7.1% vs. 6.7% and 3.0% vs. 3.0%, respectively).

BLOOM Trial Design

BLOOM, the first of three lorcaserin Phase 3 trials, is a double-blind, randomized, placebo-controlled trial in approximately 100 sites in the US. The trial evaluated 10 mg of lorcaserin dosed twice daily versus placebo over a two-year treatment period in obese patients (BMI 30 to 45) with or without co-morbid conditions and overweight patients (BMI 27 to less than 30) with at least one co-morbid condition. The trial did not include any dose titration or run-in period. Patients were randomized in a 1:1 ratio to lorcaserin or placebo at baseline. At Week 52, 856 patients taking lorcaserin were re-randomized in a 2:1 ratio to continue lorcaserin or to switch to placebo, and 697 patients on placebo were continued on placebo. Patients received echocardiograms at screening, and at 6, 12, 18 and 24 months after initiating dosing in the trial; patients with FDA-defined valvulopathy were excluded from enrolling in the trial.

Phase 3 Program Overview

The lorcaserin Phase 3 program consists of three trials: BLOOM, BLOSSOM and BLOOM-DM (Behavioral modification and Lorcaserin for Overweight and Obesity Management in Diabetes Mellitus). Enrollment in the lorcaserin Phase 3 program is complete with approximately 7,800 patients. Positive results from BLOOM were presented at the 69th Scientific Sessions of the American Diabetes Association in June 2009. BLOOM and BLOSSOM comprise the Phase 3 pivotal registration program and will be the basis for the lorcaserin NDA submission. BLOOM-DM, which is planned as a supplement to the NDA, is evaluating 10 mg of lorcaserin dosed once or twice daily versus placebo over a one-year treatment period in obese and overweight patients with type 2 diabetes at about 60 sites in the US.


'/>"/>
SOURCE Arena Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. AKELA Pharma Inc. announces positive results for the extension part of its Phase IIb Fentanyl TAIFUN(R) trial
2. UCLA/RAND study shows that many children of HIV-positive parents are not in their custody
3. Blue Cross and Blue Shield of Florida Reports Eighteenth Consecutive Year of Positive Performance
4. Nutrition model stresses positive experience of eating
5. Ultrasound plus mammography finds more cancers, but increases false positives
6. Oncolytics Biotech Inc. reports positive interim results of UK phase Ia/Ib trials
7. PEAK Surgical Announces Positive Surgical Incision Wound Healing Results With the PEAK PlasmaBlade(TM)
8. Facet Solutions AFRS(TM) Implant Demonstrates Positive Clinical Results After One Year Follow Up
9. Evotec Reports Positive Top-Line Results in Phase II Study With EVT 201 in Elderly Insomniacs With Daytime Sleepiness
10. A low prevalence of H pylori in HIV-positive patients
11. Drug Company-Funded Asthma Drug Studies More Positive
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... CA (PRWEB) May 22, 2013 ... hosted by Patricia O’Laughlin Psychotherapy in the Silver ... people of all ages as progression to existing ... of all ages into parenting therapy has always ... emphasizes. Patricia O’Laughlin Psychotherapy now specializes in all ...
(Date:5/22/2013)... ID (PRWEB) May 22, 2013 Bodybuilding.com ... This Memorial Day (May 27, 2013) Bodybuilding.com will be donating ... of the amount. , “We are extremely grateful for ... the Armed Forces,” said Ryan DeLuca, CEO and founder of ... heroes who have sacrificed so much. Hire Heroes USA is ...
(Date:5/22/2013)... According to a May 14, 2013 US News ... Breast Cancer Surgery,” modern medical technology has given women with ... in a whole new light. Since the new approach known ... breast cancer and mastectomies with greater hope for a ... of plastic surgery to oncology, women had little choice but ...
(Date:5/22/2013)... UT (PRWEB) May 22, 2013 Today, ... Alabama Health Insurance Exchange . Zane Benefits, which ... health benefits, is the leader in defined contribution ... According to Zane Benefits’ website, beginning in 2014 as ... coverage for individuals and small businesses will become available ...
(Date:5/22/2013)... from the University of Miami Miller School of Medicine ... up to hold the second annual "Why We Can,t ... The theme of this year,s conference will be ... these disparities. , Despite steady improvement in the overall ... continue to be more vulnerable to lapses in care ...
Breaking Medicine News(10 mins):Health News:Patricia O’Laughlin Psychotherapy of Los Angeles Now Seeing Adults, Teens and Young Children 2Health News:In the Spirit of Memorial Day, Bodybuilding.com is Donating a Portion of Their Sales to Hire Heroes 2Health News:Breast Augmentation – New Option for Breast Cancer Surgeries 2Health News:Zane Benefits Publishes New Information on Alabama Health Insurance Exchange 2Health News:Zane Benefits Publishes New Information on Alabama Health Insurance Exchange 3Health News:Why We Can't Wait: Conference to Eliminate Health Disparities in Genomic Medicine 2
... AIRS, a ... multiple, one-hour online classes for recruiters on the go. , ... Lebanon, NH (PRWEB) October 20, 2009 -- AIRS, a market ... Series , offering multiple, one-hour online classes for recruiters on the go. , , , ...
... ... all the loads in the new tower, including HVAC. Having a reliable standby power ... east central Florida is hit frequently by hurricanes and thunderstorms that cause disruptions in grid ... Daytona Beach, Florida ...
... American adults with chronic illnesses like diabetes or high ... increased risk of costly, disabling and even lethal complications ... [Tuesday] in Health Affairs , analyzed data from ... Disease Control and Prevention (CDC). The researchers, based at ...
... ... of Rules Technology without Spending a Dime , ... Redwood City, CA (PRWEB) October 19, 2009 -- Corticon ... today another breakthrough in the Business Rules industry with the immediate availability of Corticon ...
... Oct. 19 Today, the U.S. Department of Justice issued ... laws authorizing the use of marijuana for medical purposes. A ... States Attorneys outlined the new position of the department. , ... of these [controlled substances] priorities should not focus ...
... of Sterling Heights, Mich., pleaded guilty today in U.S. ... to defraud the Medicare program, announced Assistant Attorney General ... Terrence Berg of the Eastern District of Michigan and ... Health & Human Services (HHS). , In ...
Cached Medicine News:Health News:AIRS High Impact Series Offers Quick Solutions for Busy Recruiters 2Health News:AIRS High Impact Series Offers Quick Solutions for Busy Recruiters 3Health News:Florida's Halifax Health Relies on Standby Power System from MTU Onsite Energy for New 10-Story Emergency Facility 2Health News:Florida's Halifax Health Relies on Standby Power System from MTU Onsite Energy for New 10-Story Emergency Facility 3Health News:Illness often undiscovered and undertreated among the uninsured: Harvard study 2Health News:Corticon Launches RuleWorld Community and Free Business Rules Software 2Health News:Corticon Launches RuleWorld Community and Free Business Rules Software 3Health News:Corticon Launches RuleWorld Community and Free Business Rules Software 4Health News:Detroit-Area Physical Therapist Pleads Guilty in Medicare Fraud Scheme 2
(Date:5/22/2013)... CAESAREA, Israel , May 22, 2013 /PRNewswire/ ... data presented from the DEFLECT-I study demonstrates that Keystone ... lesion volume during TAVR (Transcatheter Aortic Valve Replacement) procedures ... Scientific Advisory Board announces consensus on the importance of ... importance and need for cerebral protection during cardiovascular procedures ...
(Date:5/22/2013)... Inc., a premier global consulting and actuarial firm, today ... (MMI), which measures the healthcare costs for a typical ... employer-sponsored preferred provider organization (PPO) plan. The cost of ... "For the second consecutive year, the ... was the lowest in the history of the study—and ...
(Date:5/22/2013)... 2013 Pomerantz Grossman Hufford Dahlstrom ... behalf of investors of Intuitive Surgical, Inc. ("Intuitive Surgical" ... 46120E602) who purchased Intuitive Surgical common stock between October ... Such investors are advised to contact Robert ... 888-476-6529, ext. 237. The investigation concerns whether ...
Breaking Medicine Technology:New Clinical Data Presented at EuroPCR Demonstrates that TriGuard Reduces Brain Lesion Volume during TAVR 2New Clinical Data Presented at EuroPCR Demonstrates that TriGuard Reduces Brain Lesion Volume during TAVR 3New Clinical Data Presented at EuroPCR Demonstrates that TriGuard Reduces Brain Lesion Volume during TAVR 4Annual Healthcare Cost for a Typical American Family is $22,030 According to 2013 Milliman Medical Index 2SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Intuitive Surgical, Inc. - ISRG 2
... Potential Benefits of Exenatide to be Prospectively Assessed in Large ... Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ) and Eli ... results from a meta-analysis of cardiovascular (CV) events that showed ... injection use compared to a pooled comparator group treated with ...
... Pre-Clinical Otelixizumab Surrogate , , NEW ORLEANS, ... engaged in the discovery and development of novel ... a pre-clinical dose-optimization study conducted with a surrogate ... at the 69th Scientific Sessions of the American ...
Cached Medicine Technology:Meta-Analysis of Clinical Data Showed No Increased Risk of Cardiovascular Events Associated With Exenatide Use: Data Presented at ADA 2009 2Meta-Analysis of Clinical Data Showed No Increased Risk of Cardiovascular Events Associated With Exenatide Use: Data Presented at ADA 2009 3Meta-Analysis of Clinical Data Showed No Increased Risk of Cardiovascular Events Associated With Exenatide Use: Data Presented at ADA 2009 4Meta-Analysis of Clinical Data Showed No Increased Risk of Cardiovascular Events Associated With Exenatide Use: Data Presented at ADA 2009 5Meta-Analysis of Clinical Data Showed No Increased Risk of Cardiovascular Events Associated With Exenatide Use: Data Presented at ADA 2009 6Tolerx Presents Data at 69th Scientific Sessions of the American Diabetes Association 2Tolerx Presents Data at 69th Scientific Sessions of the American Diabetes Association 3
Heavy Duty Locking Pliers...
The double action wire cutter has both side and end cutting capabilities....
... a combination Spectral Optical Coherence Tomography (OCT) ... provides suberb, high-quality images of the vitreo-retina, ... of spectral technology, OTI's sytem can reach ... per second and provide images with a ...
... same cryoconsole and platform technology as Freezor ... veins. Arctic Circler is an ablation tool ... that rely on medication., ,With its ... the ability to create curvilinear lesions rapidly ...
Medicine Products: